Tritonpoint Wealth, LLC Novartis Ag Transaction History
Tritonpoint Wealth, LLC
- $957 Billion
- Q1 2024
A detailed history of Tritonpoint Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 2,157 shares of NVS stock, worth $237,960. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,157
Previous 2,877
25.03%
Holding current value
$237,960
Previous $290 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,373Shares Held
141MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.37 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.36 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$801 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$664 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$653 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $237B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...